16:01 May 29

MediCaps Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
28.50
-2.97 (-9.44%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

MediCaps Ltd. Financials

MediCaps Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
28.50
-2.97 (-9.44%)
16:01 May 29
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

23/100
Expensive Valuation

Technical

36/100
Technically Neutral

Strength

7

Weakness

4

Opportunity

0

Threats

0

-2.72 %

ROE %

-2.63 %

ROA %

-2.44

EPS

89.50

BVPS

-24.40 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
69.87 49.37 27.35 25.48 12.45
Operating Expenses +
59.92 44.31 27.38 27.31 21.86
Raw Material
30.05 22.05 8.43 10.17 5.44
Increase Decrease in Cost
0.06 0.85 1.09 0.48 0.2
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
7.71 7.69 7.07 7.58 7.74
Miscellaneous Expenses
22.1 13.72 10.79 9.08 8.48
Operating Profit
9.95 5.06 -0.03 -1.83 -9.41
Other Income
1.91 1.6 0.48 2.73 8.21
Depreciation
1.81 1.74 1.69 1.72 1.81
Interest
0 0 0 0.02 0.01
Profit before tax and exceptio..
10.06 4.92 -1.25 -0.84 -3.02
Exceptional Items
0 0 0 0 0
PBT
10.06 4.92 -1.25 -0.84 -3.02
Provision for Taxation
0.01 3.05 0.99 -0.27 0.01
Net Profit
10.08 1.76 -2.24 -0.57 -3.04
NET Profit after MI
10.08 1.76 -2.24 -0.57 -3.04
EPS
8.08 1.41 -1.8 -0.46 -2.44
Operating Profit Margin (%)
14.24 10.25 -0.11 -7.18 -75.58
Net Profit Margin (%)
14.43 3.56 -8.19 -2.24 -24.42

MediCaps Ltd. Shareholding

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 51.40 50.80 50.80 50.80 50.80 50.60
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 48.60 49.20 49.20 49.20 49.20 49.40
Shareholder Shares Holding %
Download Our App On: